inghu ... I read and replied to your post in haste (was literally on the way out the door).
I'd have no problem with a JV made with a wholly owned BPRG sub (Dexo) -- love the idea of a big pharma providing the capital support and maybe personnel support. But you seemed to be saying they might also be setting the new company up for the purpose of selling wafertab, eventually. In your mind, would that be a good thing? And what would be sold -- the technology? The relevant patents? Both? Coudln't the same questions be asked of any of the products-in-the-mill -- would certain ones (plus patents?) be sold and not others?
As always, I have no idea what's in RT & DF's minds, what direction they want to take the company.